Fujifilm to Set Up iPS Cell Production Facility in U.S.
Tokyo, Dec. 20 (Jiji Press)–Japan’s Fujifilm Corp. said Thursday it will spend some 2.5 billion yen to set up in the United States a facility to produce induced pluripotent stem, or iPS, cells for treatment purposes.
The company, under the wing of Fujifilm Holdings Corp. <4901>, hopes to have the facility start operating during fiscal 2019, which begins in April next year.
JIJI PRESS